Ustekinumab
Ustekinumab is an active ingredient in 41 FDA-listed drug products sold under 11 names.
Drugs containing Ustekinumab
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 65219-826 | Otulfi Injection, Solution | 90 mg/mL | Fresenius Kabi USA, LLC |
| 65219-824 | Otulfi Injection, Solution | 45 mg/.5mL | Fresenius Kabi USA, LLC |
| 65219-822 | Otulfi Injection, Solution | 45 mg/.5mL | Fresenius Kabi USA, LLC |
| 65219-828 | Otulfi Solution | 130 mg/26mL | Fresenius Kabi USA, LLC |
| 83457-651 | Pyzchiva Injection, Solution | 45 mg/.5mL | Cordavis Limited |
| 83457-652 | Pyzchiva Injection, Solution | 90 mg/mL | Cordavis Limited |
| 61314-651 | Pyzchiva Injection, Solution | 45 mg/.5mL | SANDOZ INC |
| 61314-654 | Pyzchiva Injection, Solution | 130 mg/26mL | SANDOZ INC |
| 61314-652 | Pyzchiva Injection, Solution | 90 mg/mL | SANDOZ INC |
| 50090-7769 | Selarsdi Injection, Solution | 90 mg/mL | A-S Medication Solutions |
| 0143-9170 | Starjemza Injection | 90 mg/mL | Hikma Pharmaceuticals USA Inc. |
| 0143-9168 | Starjemza Injection | 45 mg/.5mL | Hikma Pharmaceuticals USA Inc. |
| 0143-9171 | Starjemza Injection | 130 mg/26mL | Hikma Pharmaceuticals USA Inc. |
| 0143-9169 | Starjemza Injection | 45 mg/.5mL | Hikma Pharmaceuticals USA Inc. |
| 57894-061 | Stelara Injection, Solution | 90 mg/mL | Janssen Biotech, Inc. |
| 57894-060 | Stelara Injection, Solution | 45 mg/.5mL | Janssen Biotech, Inc. |
| 57894-054 | Stelara Solution | 130 mg/26mL | Janssen Biotech, Inc. |
| 72606-027 | Steqeyma Injection, Solution | 45 mg/.5mL | CELLTRION USA, Inc. |
| 72606-028 | Steqeyma Injection, Solution | 90 mg/mL | CELLTRION USA, Inc. |
| 72606-060 | Steqeyma Injection, Solution | 45 mg/.5mL | CELLTRION USA, Inc. |
| 72606-029 | Steqeyma Injection, Solution | 130 mg/26mL | CELLTRION USA, Inc. |
| 57894-440 | Ustekinumab Injection, Solution | 45 mg/.5mL | Janssen Biotech, Inc. |
| 57894-441 | Ustekinumab Injection, Solution | 90 mg/mL | Janssen Biotech, Inc. |
| 57894-444 | Ustekinumab Solution | 130 mg/26mL | Janssen Biotech, Inc. |
| 65219-862 | Ustekinumab-aauz Injection, Solution | 45 mg/.5mL | Fresenius Kabi USA, LLC |
| 65219-866 | Ustekinumab-aauz Injection, Solution | 90 mg/mL | Fresenius Kabi USA, LLC |
| 82009-160 | Ustekinumab-ttwe Injection, Solution | 45 mg/.5mL | Quallent Pharmaceuticals Health LLC |
| 82009-163 | Ustekinumab-ttwe Injection, Solution | 130 mg/26mL | Quallent Pharmaceuticals Health LLC |
| 82009-161 | Ustekinumab-ttwe Injection, Solution | 45 mg/.5mL | Quallent Pharmaceuticals Health LLC |
| 82009-162 | Ustekinumab-ttwe Injection, Solution | 90 mg/mL | Quallent Pharmaceuticals Health LLC |
| 84612-066 | Wezlana Injection, Solution | 130 mg/26mL | Nuvaila Limited |
| 84612-889 | Wezlana Injection, Solution | 90 mg/mL | Nuvaila Limited |
| 84612-055 | Wezlana Injection, Solution | 45 mg/.5mL | Nuvaila Limited |
| 84612-855 | Wezlana Injection, Solution | 45 mg/.5mL | Nuvaila Limited |
| 84612-089 | Wezlana Injection, Solution | 90 mg/mL | Nuvaila Limited |
| 84612-076 | Wezlana Injection, Solution | 45 mg/.5mL | Nuvaila Limited |
| 84612-876 | Wezlana Injection, Solution | 45 mg/.5mL | Nuvaila Limited |
| 83257-024 | Yesintek Injection, Solution | 45 mg/.5mL | Biocon Biologics Inc. |
| 83257-026 | Yesintek Solution | 130 mg/26mL | Biocon Biologics Inc. |
| 83257-023 | Yesintek Injection, Solution | 45 mg/.5mL | Biocon Biologics Inc. |
| 83257-025 | Yesintek Injection, Solution | 90 mg/mL | Biocon Biologics Inc. |